Between 15 and 20% of primary invasive breast carcinomas show overexpression and/or amplification of the Human Epithelial Growth Factor Receptor-2 (HER2), a transmembrane glycoprotein with tyrosine-kinase activity encoded by the ERBB2 gene on chromosome 17 (17q12). The gene discussed is ERBB2; the disease is invasive breast carcinoma.